158 related articles for article (PubMed ID: 29299501)
1. Giant Cell Tumor of the Sacrum: Series of 19 Patients and Review of the Literature.
Jamshidi K; Bagherifard A; Mirzaei A; Bahrabadi M
Arch Bone Jt Surg; 2017 Nov; 5(6):443-450. PubMed ID: 29299501
[TBL] [Abstract][Full Text] [Related]
2. Conservative surgery in the treatment of giant cell tumor of the sacrum: 35 years' experience.
Domovitov SV; Chandhanayingyong C; Boland PJ; McKeown DG; Healey JH
J Neurosurg Spine; 2016 Feb; 24(2):228-240. PubMed ID: 26516662
[TBL] [Abstract][Full Text] [Related]
3. Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone.
Yacob O; Umer M; Gul M; Qadir I
J Orthop Surg (Hong Kong); 2016 Apr; 24(1):88-91. PubMed ID: 27122520
[TBL] [Abstract][Full Text] [Related]
4. [The analysis of the treatment of giant cell tumor of the pelvis and sacrum].
Guo W; Tang XD; Li X; Ji T; Sun X
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(7):501-5. PubMed ID: 18785558
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage.
Chen KH; Wu PK; Chen CF; Chen WM
Eur Spine J; 2015 Oct; 24(10):2182-8. PubMed ID: 25940568
[TBL] [Abstract][Full Text] [Related]
6. Giant cell tumors of the sacrum--a nationwide study on midterm results in 26 patients after intralesional excision.
van der Heijden L; van de Sande MA; van der Geest IC; Schreuder HW; van Royen BJ; Jutte PC; Bramer JA; Öner FC; van Noort-Suijdendorp AP; Kroon HM; Dijkstra PD
Eur Spine J; 2014 Sep; 23(9):1949-62. PubMed ID: 24614982
[TBL] [Abstract][Full Text] [Related]
7. [Surgical treatment of giant cell tumors with pathological fracture around the knee].
Liu WF; Yang FJ; Li Y; Li B; Hao L; Niu XH
Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):677-686. PubMed ID: 30157574
[No Abstract] [Full Text] [Related]
8. A novel three-dimensional-printed patient-specific sacral implant for spinopelvic reconstruction in sacral giant cell tumour.
Lv Z; Li J; Yang Z; Li X; Yang Q; Li Z
Int Orthop; 2023 Jun; 47(6):1619-1628. PubMed ID: 36928708
[TBL] [Abstract][Full Text] [Related]
9. Intralesional nerve-sparing surgery versus non-surgical treatment for giant cell tumor of the sacrum.
Tsukamoto S; Ali N; Mavrogenis AF; Honoki K; Tanaka Y; Spinnato P; Donati DM; Errani C
BMC Musculoskelet Disord; 2021 Dec; 22(1):1023. PubMed ID: 34872538
[TBL] [Abstract][Full Text] [Related]
10. Decision making in primary sacral tumors.
Puri A; Agarwal MG; Shah M; Srinivas CH; Shukla PJ; Shrikhande SV; Jambhekar NA
Spine J; 2009 May; 9(5):396-403. PubMed ID: 19059810
[TBL] [Abstract][Full Text] [Related]
11. Conservative surgery for giant cell tumors of the sacrum. The role of cryosurgery as a supplement to curettage and partial excision.
Marcove RC; Sheth DS; Brien EW; Huvos AG; Healey JH
Cancer; 1994 Aug; 74(4):1253-60. PubMed ID: 8055446
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for the local recurrence of giant cell tumours of the sacrum treated with nerve-sparing surgery.
Zhao Y; Tang X; Yan T; Ji T; Yang R; Guo W
Bone Joint J; 2020 Oct; 102-B(10):1392-1398. PubMed ID: 32993346
[TBL] [Abstract][Full Text] [Related]
13. Analysis of clinical outcome for adolescent patients undergoing conservative nerve-sparing surgery based on the proposed resection classification for sacral giant cell tumor.
Wang J; Du Z; Yang R; Tang X; Yan T; Guo W
J Clin Neurosci; 2020 Oct; 80():23-29. PubMed ID: 33099351
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
[TBL] [Abstract][Full Text] [Related]
15. Surgical strategy for the management of sacral giant cell tumors: a 32-case series.
Li G; Fu D; Chen K; Ma X; Sun M; Sun W; Li J; Cai Z
Spine J; 2012 Jun; 12(6):484-91. PubMed ID: 22801004
[TBL] [Abstract][Full Text] [Related]
16. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
Agarwal MG; Gundavda MK; Gupta R; Reddy R
Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
[TBL] [Abstract][Full Text] [Related]
17. Can Navigation-assisted Surgery Help Achieve Negative Margins in Resection of Pelvic and Sacral Tumors?
Abraham JA; Kenneally B; Amer K; Geller DS
Clin Orthop Relat Res; 2018 Mar; 476(3):499-508. PubMed ID: 29529631
[TBL] [Abstract][Full Text] [Related]
18. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.
Errani C; Tsukamoto S; Leone G; Akahane M; Cevolani L; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM
Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):813-819. PubMed ID: 28589498
[TBL] [Abstract][Full Text] [Related]
19. Wide resection versus curettage with adjuvant therapy for giant cell tumour of bone.
Kamal AF; Simbolon EL; Prabowo Y; Hutagalung EU
J Orthop Surg (Hong Kong); 2016 Aug; 24(2):228-31. PubMed ID: 27574268
[TBL] [Abstract][Full Text] [Related]
20. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
